Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
about
Adenoviral vectors for prodrug activation-based gene therapy for cancerCancer gene therapy using a survivin mutant adenovirusOncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coliA new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinomaA novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer.Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.Transcriptional control of viral gene therapy by cisplatinArmed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider.Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.Transcriptionally targeted gene therapy to detect and treat cancer.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Tissue-specific promoters for cancer gene therapy.Oncolytic viral therapies.Replication-selective oncolytic viruses in the treatment of cancer.Conditionally replicating adenoviruses for cancer treatment.Adenoviruses for treatment of cancer.Oncolytic adenoviruses - selective retargeting to tumor cells.Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application.Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors.Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma.Antitumor activity and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV) -mediated Bmi-1 interference driven by Bmi-1 promoter for gastric cancer.An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors.Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells.Armed replicating adenoviruses for cancer virotherapy.Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.Enhancing biological therapy through conditional regulation of protein stability.Oncolytic (replication-competent) adenoviruses as anticancer agents.Clinical development directions in oncolytic viral therapy.Oncolytic viruses in the treatment of cancer: a review of current strategies.Oncolytic viruses: adenoviruses.Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer.Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.
P2860
Q26860729-E266DD52-BFC3-47E0-A628-4EFF6239B359Q28360690-C3D4C702-26A6-4510-A262-C9D699D3D2A0Q33234192-405831F0-158A-491B-A006-A9F1DE103CD0Q33252754-9536E239-6A3C-4463-A37F-D239A326F780Q33299767-CFF860F7-AEC4-438C-BB88-CC60494E8DE2Q33710438-6F1D32F2-2665-4189-B758-220E7947E0FDQ33868732-2A51DB74-3B3E-47FA-9172-2B5828608A4CQ34273617-8705D763-D636-4F8B-B9BE-C0EBED013AAEQ34293607-6CBB8A78-3E12-41AA-92D2-7CDD7C270B8DQ34297058-CE4E3457-C6D9-4BA8-BF8D-569A494CE08BQ34335982-C426F160-7105-4DA3-9C15-6702D15B05F3Q34795177-E17B3B23-C036-4EC0-970F-91033C6C6900Q35043106-DB0C20EC-ABF7-4A1F-BA7B-F56F2B018221Q35043121-3DF73547-3172-4108-ABDC-A1A5BC9C1D8FQ35058583-988B5C48-01DC-4412-9D19-01D2E4F0FE98Q35100683-9EE8ABF1-3E55-428E-9B2F-E48E707EC7AEQ35558678-16AB0DC7-D2E6-4FCB-B8A2-B26C8E667299Q35624010-C1C98B01-0B98-4047-B087-001C7859C95AQ35779378-8A74F105-B5D7-460B-9D8E-1E25430D410EQ35852258-C39A0E58-C1E8-4ED2-AA72-3C9C4EBDBC6FQ35912403-4CEEF13B-CF8D-4753-B21D-2E70562639AEQ35967313-4976EECE-DE42-4B93-8D9D-982D92ECA411Q36132288-D887D403-F39A-4872-83F7-CCA7567E77E6Q36318189-FC70114D-733F-412C-A6BC-7D22CAF77070Q36387929-5E715609-7E07-40C1-AB34-51D95AC47293Q36675446-553CDF9F-CF0A-4322-AEC3-2B4F70951C72Q37212969-3FF531D4-72BC-47F1-A404-434445AD4EDAQ37225659-14BF0363-ABD2-4A12-8EBF-2BA2A009FD23Q37316842-19ECFD89-6C95-4243-B642-0CED086AA39DQ37360204-66A5AA08-8F84-447C-8FBA-32518B105291Q37362758-AE827F4B-D808-437A-8609-EC0E9C41D134Q37386616-A5F222AF-ABE8-46D6-B88A-385D517E9BD8Q37437464-CA861AE9-6DF6-4B00-A8DC-BEFC20B537BEQ37671855-C575FB9D-A81D-426D-8D79-A1B6D1EA9AF1Q37687415-8EC7FBCC-3817-4968-AA27-4AC4A3CF747DQ37857659-67615080-6F5E-46F8-8DAF-73DA55BD655AQ38020107-F7EA7AD6-B8EE-44B5-AD04-02B8C32C8453Q39432063-4C01824F-E4DC-4474-8E5B-79C530533E69Q39451790-B1885478-3A75-4BEA-85C8-EB7A38A429F0Q39652106-06A409FE-FAAD-426E-8F9B-92A2AF5C19B1
P2860
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@en
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@nl
type
label
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@en
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@nl
prefLabel
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@en
Selectivity of a replication-c ...... s expressing the MUC1 antigen.
@nl
P2093
P2860
P356
P1476
Selectivity of a replication-c ...... ls expressing the MUC1 antigen
@en
P2093
P2860
P304
P356
10.1172/JCI9180
P407
P50
P577
2000-09-01T00:00:00Z